Article in Frontiers in cell and developmental biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
2 citing papers in PubMed, 2 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
5 authors at 1 institution in 1 country.
Xue LinDepartment of Pediatrics, Division of Infectious Diseases, Washington University School of Medicine, St. Louis, MO, United States.
Praveen KrishnamoorthyWashington University Center for Cellular Imaging, Washington University School of Medicine, St. Louis, MO, United States.
Emma C WalkerDepartment of Pediatrics, Division of Infectious Diseases, Washington University School of Medicine, St. Louis, MO, United States.
Hemant JoshiDepartment of Pediatrics, Division of Infectious Diseases, Washington University School of Medicine, St. Louis, MO, United States.
Sharon Celeste MorleyDepartment of Pediatrics, Division of Infectious Diseases, Washington University School of Medicine, St. Louis, MO, United States.
Washington University in St. Louis · US
Funding
Strength of TCR:self-pMHC interactions in the periphery instructs CD4+ T help cell responsesR01AI139540 · NIAID · WASHINGTON UNIVERSITY · PI MORLEY, SHARON CELESTE · 2019 to 2023
$2.3M
Targeting the NLRP3 inflammasome to limit pathologic sterile inflammationR01AI118719 · NIAID · CEDARS-SINAI MEDICAL CENTER · PI SUTTERWALA, FAYYAZ S. · 2016 to 2020
$2.2M
CONTROL OF ADAPTIVE IMMUNITY BY ACTIN-REGULATORY PROTEINSR01AI104732 · NIAID · WASHINGTON UNIVERSITY · PI MORLEY, SHARON CELESTE · 2014 to 2018
$1.9M
Targeting chitin in fibrotic lung diseaseR01HL148033 · NHLBI · WASHINGTON UNIVERSITY · PI VAN DYKEN, STEVEN · 2020 to 2023
$1.7M
ZEISS LSM880 AIRYSCAN MICROSCOPE FOR SHARED BIOMEDICAL RESEARCHS10OD021629 · OD · WASHINGTON UNIVERSITY · PI FITZPATRICK, JAMES ALEXANDER · 2017 to 2017
$596k
Multifunctional Nanoprobe for Early Appraisal of Immunotherapeutic EfficacyR21EB030171 · NIBIB · WASHINGTON UNIVERSITY · PI MORRISSEY, JEREMIAH J, SINGAMANENI, SRIKANTH · 2021 to 2022
$433k
Actin regulatory proteins regulate alveolar macrophage pro-inflammatory signalingR56AI104732 · NIAID · WASHINGTON UNIVERSITY · PI MORLEY, SHARON CELESTE · 2020 to 2020
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Expression of non-phosphorylatable S5A-L-plastin exerts phenotypes distinct from L-plastin deficiency during podosome formation and phagocytosis. · full record | OpenQuestion